支气管洗稀释难题:对一个长期存在的问题进行了更新
Sarah Haeger1, Camille M Moore2, Shannon A McManus3
1Department of Medicine, University of Colorado, Aurora, Colorado, United States.
概括
支气管洗 (BAL) 稀释标记通常是不可靠的. 表面活性蛋白D显示为更准确的肺液测量标记物,在健康和炎症状态中具有前途.
科学领域:
- 肺部医学 肺部医学
- 翻译研究是翻译研究.
- 生物标志物发现发现
背景情况:
- 支气管支气管洗 (BAL) 对于研究肺部分子相互作用至关重要.
- 由于上皮层内液 (ELF) 的稀释和不一致的收集,BAL液的准确解释受到阻碍.
- 内源标记物用于使BAL液体测量正常化,但具有局限性.
研究的目的:
- 审查影响肺ELF无细胞分子测量的因素.
- 为了比较各种BAL稀释标记在健康和急性炎症中的性能.
- 为了确定更可靠的标记物用于BAL液体正常化.
主要方法:
- 对影响BAL标志物解释因素的文献综述.
- 尿素,总蛋白质,白蛋白,IgM和表面活性蛋白D的性能比较.
- 在人类内毒素挑战模型中利用数学预测模型和现实世界的测量.
主要成果:
- 通常使用的标记物 (尿素,蛋白质,白蛋白,IgM) 由于混合不完整和炎症等因素而不可靠.
- 表面活性蛋白D表现出更高的稳定性和更少的易受干扰因素的影响.
- 炎症显著影响传统BAL稀释标记物的性能.
结论:
- 已建立的BAL稀释标记可能对正常化非细胞测量不准确.
- 表面活性蛋白D是BAL液的更可靠和生物可信的标记物.
- 对于严格的翻译性肺研究,需要改进正常化策略.
相关概念视频
Pulmonary Cycle: Exhalation
5.2K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
3.7K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
3.7K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24


